HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A mimic of tumor rejection antigen-associated carbohydrates mediates an antitumor cellular response.

Abstract
Tumor-associated carbohydrate antigens are typically perceived as inadequate targets for generating tumor-specific cellular responses. Lectin profile reactivity and crystallographic studies demonstrate that MHC class I molecules can present to the immune system posttranslationally modified cytosolic peptides carrying O-beta-linked N-acetylglucosamine (GlcNAc). Here we report that a peptide surrogate of GlcNAc can facilitate an in vivo tumor-specific cellular response to established Meth A tumors that display native O-GlcNAc glycoproteins on the tumor cell surface. Peptide immunization of tumor-bearing mice had a moderate effect on tumor regression. Inclusion of interleukin 12 in the immunization regimen stimulated complete elimination of tumor cells in all of the mice tested, whereas interleukin 12 administration alone afforded no tumor growth inhibition. Adoptive transfer of immune T cells into tumor-bearing nude mice indicates a role for CD8+ T cells in tumor regression. This work postulates that peptide mimetics of glycosylated tumor rejection antigens might be further developed for immune therapy of cancer.
AuthorsBehjatolah Monzavi-Karbassi, Ping Luo, Fariba Jousheghany, Marta Torres-Quiñones, Gina Cunto-Amesty, Cecile Artaud, Thomas Kieber-Emmons
JournalCancer research (Cancer Res) Vol. 64 Issue 6 Pg. 2162-6 (Mar 15 2004) ISSN: 0008-5472 [Print] United States
PMID15026358 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, Tumor-Associated, Carbohydrate
  • Histocompatibility Antigens Class I
  • Peptide Fragments
  • Interleukin-12
  • Interferon-gamma
  • Acetylglucosamine
Topics
  • Acetylglucosamine (immunology)
  • Animals
  • Antigen Presentation
  • Antigens, Tumor-Associated, Carbohydrate (immunology, metabolism, therapeutic use)
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cytosol (metabolism)
  • Female
  • Histocompatibility Antigens Class I (immunology, metabolism)
  • Humans
  • Immunization
  • Immunotherapy
  • Interferon-gamma (metabolism)
  • Interleukin-12 (therapeutic use)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Molecular Mimicry
  • Peptide Fragments (immunology, metabolism, therapeutic use)
  • Sarcoma, Experimental (immunology, pathology, prevention & control)
  • Spleen (immunology)
  • T-Lymphocytes, Cytotoxic (drug effects, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: